echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Latest Medical News > The growth rate of the centrifuge market exceeds 23%, and the biomedical industry is a major "support force" behind it

    The growth rate of the centrifuge market exceeds 23%, and the biomedical industry is a major "support force" behind it

    • Last Update: 2022-03-06
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    Relevant data shows that in 2021, centrifuge products will outperform the central air-conditioning industry with a growth rate of 23.
    89%, becoming one of the few growth models in chillers
    .
    Biomedicine (Photo source: Pharmaceutical Network) Behind the rapid growth of centrifuge products, its application range is very wide
    .
    Whether it is in the fields of data centers, new materials, chip manufacturing, new energy, or biomedicine, there are centrifuges.
    These market segments will have a strong development momentum in 2021, bringing great opportunities to the centrifuge market
    .
    Taking the biomedical industry as an example, biomedicine is mainly divided into vaccines, blood products, diagnostic reagents and monoclonal antibodies
    .
    In recent years, with the intensification of aging and the continuous upgrading of people's consumption levels, the entire biopharmaceutical industry has ushered in rapid development
    .
    Since 2020, the development of the biopharmaceutical industry, especially the vaccine, diagnosis and other industries, has received further attention, and relevant favorable policies have been issued frequently to support the development and growth of China's biopharmaceutical enterprises
    .
    At the same time, capital and talents are also entering the field at an accelerated pace, and the entire industry is in a state of vigorous development.
    CDMOs, biopharmaceuticals, etc.
    have sprung up, which has indirectly driven the growth of the market demand for medical centrifuge equipment and has become a major market growth in this industry.
    "Support"
    .
    Many powerful domestic medical centrifuge manufacturers said that in 2021, the company has received a good order growth due to the good it has undertaken
    .
    Moreover, while meeting the domestic market demand, there are also a number of domestic centrifuge companies with strong brands that continue to successfully deliver their products overseas
    .
    For example, a medical centrifuge manufacturer said, "Since 2020, the company's overseas customers have received orders one after another, and the products have been successfully shipped to many overseas countries and regions, and overseas business has also brought a lot of contributions to the company's performance
    .
    " However, From the perspective of the market structure, the domestic medical centrifuge market is still dominated by imported products, especially in the mid-to-high-end field, where domestic medical centrifuges almost lack the right to speak.
    Very few
    .
    This also means that domestic medical centrifuges need to be upgraded quickly and strive to transform from low-end to mid-to-high-end
    .
    In 2021, as Midea Building Technology rolled off its 1,000th centrifuge, it means that China's centrifuge market has ushered in an inflection point
    .
    The industry believes that starting from 2022, central air conditioners will enter the peak period when Chinese brands overtake foreign brands
    .
    Another industry analyst predicts that in the next 5-10 years, domestic centrifuge brands will usher in a new stage of high-quality development
    .
    This also means that in the future, the space for domestic centrifuge equipment to replace imports will be opened, and centrifuge manufacturers with related layouts may usher in greater opportunities
    .
    A new outlet has emerged
    .
    Some medical centrifuge manufacturers said that facing the future, the company will continue to increase investment in research and development, attach importance to innovation, continuously improve the stability and quality of domestic centrifuges, seize the opportunity of import substitution, and help the pharmaceutical and other industries to develop with higher quality
    .
    It is worth mentioning that while the domestic medical centrifuge industry is facing opportunities, it is also facing new challenges
    .
    For example, under the dual-carbon goal, centrifuges need to be upgraded in a more energy-saving, low-carbon, and high-quality direction; for another example, with the rising cost of pharmaceutical companies in all aspects, pharmaceutical companies also pay more attention to the cost performance of centrifuges.
    How to improve The economy of products is also a direction that major centrifuge manufacturers need to improve and a problem that needs to be considered
    .
    Disclaimer: Under no circumstances does the information or opinions expressed in this article constitute investment advice to anyone
    .
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.